IDEXX Laboratories (NASDAQ:IDXX) reported Q4 2017 earnings this Morning, coming in at $0.77 per share, beating Wall Street’s estimates of $0.73 per Share. Revenue for the quarter came in at $506.00 million beating analyst estimates of $490.51 million Recent Insider Trading for IDEXX Laboratories (NASDAQ:IDXX)
- On 1/11/2018 Jonathan W Ayers, CEO, sold 2,160 with an average share price of $167.03 per share and the total transaction amounting to $360,784.80.
- On 1/9/2018 Jonathan W Ayers, CEO, sold 18,000 with an average share price of $165.15 per share and the total transaction amounting to $2,972,700.00.
- On 11/30/2017 Giovani Twigge, Insider, sold 2,000 with an average share price of $156.07 per share and the total transaction amounting to $312,140.00.
- On 11/16/2017 Jonathan W Ayers, CEO, sold 18,000 with an average share price of $153.61 per share and the total transaction amounting to $2,764,980.00.
- On 11/14/2017 Jonathan W Ayers, CEO, sold 18,000 with an average share price of $148.35 per share and the total transaction amounting to $2,670,300.00.
- On 11/7/2017 Jonathan W Ayers, Chairman, sold 54,000 with an average share price of $151.32 per share and the total transaction amounting to $8,171,280.00.
Recent Trading for IDEXX Laboratories (NASDAQ:IDXX) Shares of IDEXX Laboratories closed the previous trading session at with 189.52999877929688 shares trading hands.